Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL483465

ELRAGLUSIB
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3

Basic Information

ChEMBL ID CHEMBL483465
Name ELRAGLUSIB
Phase Phase II
Structure Type MOL
InChI Key FARXPFGGGGLENU-UHFFFAOYSA-N

Known Names

9 ing 41 9-ing-41 Elraglusib
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
3
Known Names
12
Indications
1
Mechanisms

Molecular Properties

404.4
MW (Da)
3.36
ALogP
6
HBA
1
HBD
82.7
PSA (Ų)
0.52
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Year 2021

Extended Properties

Molecular Formula C22H13FN2O5
MW 404.35
Aromatic Rings 4
Heavy Atoms 30
NP-Likeness -0.19

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Glycogen synthase kinase-3 beta inhibitor INHIBITOR Glycogen synthase kinase-3 beta

Indications

Bone Neoplasms Bone Neoplasms Breast Neoplasms Glioma Kidney Neoplasms Lung Neoplasms Lymphoma, Non-Hodgkin Neoplasm Metastasis Pancreatic Neoplasms Primary Myelofibrosis Sarcoma Neoplasms

Activity Summary

IC50 4 meas. best 6.22

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
HuP-T3
CHEMBL1075477
IC50 6.22 6.22 600.0 1
Glycogen synthase kinase-3 beta
CHEMBL262
IC50 6.15 6.15 710.0 1
BXPC-3
CHEMBL614530
IC50 6.0 6.0 1000.0 1
MIA PaCa-2
CHEMBL614725
IC50 5.3 5.3 5000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
19338355 10.1021/jm801317h BXPC-3 3
19338355 10.1021/jm801317h Glycogen synthase kinase-3 beta 2
19338355 10.1021/jm801317h MIA PaCa-2 1
19338355 10.1021/jm801317h HuP-T3 1

Data from ChEMBL 36 via Core Engine